Biocon Biologics, a subsidiary of Biocon, on Monday got approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India ...
IBTmes India
5 days ago
CNBC Awaaz
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker hardsells airport play
12 hours ago
Biocon gets 4 observations from USFDA for Andhra facility
6 days ago
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
The Economic Times
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
Livemint
Stocks to buy: Federal Bank, Biocon, among top picks by SMC Global for this week
3 days ago
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹351.00 +4.85 (+1.40%)
Fri, Jun 28, 2024, 6:00AM EDT